GovChime
UEI: DTLFCU5DAXV4 • CAGE: 87AL5
Active

ACURX PHARMACEUTICALS INC (NY)

Registration facts

SAM.gov registration as of

SAM.gov registration status
Active (registration expiration date Mar 11, 2027)
UEI
DTLFCU5DAXV4
CAGE code
87AL5
Entity structure
Corporate Entity (Not Tax Exempt)
Business start date
Jul 19, 2017
Location
STATEN ISLAND, NY
Website
acurxpharmaceuticals.com

Product and service codes (PSC)

  • 6505 DRUGS AND BIOLOGICALS

SBA certifications

No certification in the SBA profile data.

Other contractors in New York with primary NAICS 621511

All federal contractors in New YorkHow these figures are built

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI DTLFCU5DAXV4. GovChime does not check exclusions.

Key Performance Statistics

View obligations by year, agencies and performance history

Create free accountCreate free account

Capabilities

NAICS Codes

See all industry codes with contract counts

Create free accountCreate free account

Product/Service Codes

As of . Source: SAM.gov Goods & Services.

6505- DRUGS AND BIOLOGICALS

Certifications

Business Types

For Profit OrganizationBusiness or Organization

Federal Capability Statement

Early stage biopharmaceutical company focused on development of antibiotics that address difficult to treat bacterial infections. Acurx's approach to counter the emergence of antibiotic-resistant bacterial infections is to develop new antibiotics that effectively block an entirely new molecular target, DNA polymerase IIIC enzyme.

Capabilities & Services

DNA polIIC inhibitor; DNA polymerase inhibitor
low GC bacterial infections

Contracts

Explore federal contract awards with detailed transaction history

Create free accountCreate free account

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for ACURX PHARMACEUTICALS INC lists a physical address and a separate mailing address, along with 2 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

259 LIBERTY AVE

STATEN ISLAND, NY, 10305

USA

Mailing Address

259 Liberty Ave

Staten Island, NY, 10305

USA

Government Business Contact

Robert G Shawah

Chief Financial Officer

259 Liberty Ave

Staten Island, NY, 10305

USA

Electronic Business Contact

Robert G Shawah

Chief Financial Officer

259 Liberty Ave

Staten Island, NY, 10305

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

ACURX PHARMACEUTICALS INC has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires March 11, 2027.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

No active suspension or debarment

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Registered for disaster relief contracting

Bonding Information

No bonding information provided

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Entity Structure:Corporate Entity (Not Tax Exempt)
Profit Structure:For Profit Organization
CAGE Code:87AL5

Registration Details

Source: SAM.gov

Date Founded

Jul 19, 2017

Initial Registration

Nov 7, 2018

Last Update

Mar 13, 2026

Registration Activation

Active — Mar 13, 2026

Registration Expiration

Mar 11, 2027

Fiscal Year End

12/31

State of Incorporation

DE

Country of Incorporation

USA

Congressional District

11